Corcept Therapeutics

CORT

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitiga …

Insider trades and stock quote 2022-2024

All insider trades at Corcept Therapeutics

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
3/18/2024 SellMaduck, Sean Officer $25.0 $430,475
3/1/2024 SellSwisher, Daniel N Jr Director $23.6 $51,898
2/16/2024 SellMaduck, Sean Officer $26.0 $702,905
2/16/2024 SellLyon, Joseph Douglas Chief Accounting Officer $26.0 $26,000
2/15/2024 SellMaduck, Sean Officer $25.0 $119,000
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)